Viewing Study NCT04524351

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-05-05 @ 9:07 AM
Study NCT ID: NCT04524351
Status: COMPLETED
Last Update Posted: 2023-02-28
First Post: 2020-08-11
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients
Sponsor: Annovis Bio Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer Disease View
None Parkinson Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Safety View
None Tolerability View
None Pharmacokinetics View
None Pharmacodynamics View
None Neurotoxic proteins View
None Neurotransmitters View
None Amyloid Precursor Proteins View
None Inflammatory factors View
None Synaptic factors View
None CSF View